FindTrial
Sign In

Comparision of Lajadi kalka and Kutaja choorna in treatment of acute childhood Diarrohea

RANDOMIZED CONTROLLED CLINICAL TRIAL OF LAJADI KALKA IN MANAGEMENT OF BALATISARA WITH SPECIAL REFERENCE TO ACUTE DIARRHEA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028522
Enrollment
60
Registered
2020-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R197- Diarrhea, unspecified

Interventions

Intervention1: LAJADI KALKA: LAJADI KALKA will be prepared from the crude drug bought from market will be given orally twice a day for 9 days, patient will be follow up on 3rd,6th,9th day. Control Int

Sponsors

Principal LKR Ayurvedic Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient suffering from Acute Diarrhea with no Dehydration and some Dehydration

Exclusion criteria

Exclusion criteria: Patient suffering from severe Dehydration. Patient suffering from juvenile diabetes,genetic disorders,hypothyroidism,HIV,Hep B and critically ill patient. Patient who is immune compromised.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of LAJADI KALKA two times a day is as effective as KUTAJA CHOORNA two times a day in management of Balatisara (Acute Childhood Diarrhea)Timepoint: 9 DAYS—

Secondary

MeasureTime frame
1. To evaluate adverse effects of any. 2.To evaluate the effectiveness of Lajadi kalka in management of acute Diarrhea. 3.To evaluate the effectiveness of Kutaja choorna in management of acute Diarrhea.Timepoint: 9 days—

Countries

India

Contacts

Public ContactDr Nitin Shingare

LKR Ayurvedic Mahavidyalya and Research Center

nitinshingare20@gmail.com8275303274

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026